Clozapine-induced type-2 diabetes mellitus: Possible mechanisms and implications for clinical practice

Journal of Psychopharmacology

Volumn 19, Issue 2, 2005, Pages 207-210

  Tovey, Elizabeth ^a   Rampes, Hagen ^b   Livingstone, Callum ^c  

^a WEST LONDON MENTAL HEALTH NHS TRUST   (United Kingdom)

^b Barnet Enfield Haringey Mental H   (United Kingdom)

^c ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

Author keywords

Adverse effect; Antipsychotic; Diabetes mellitus; Dozapine; Schizoaffective disorder; Schizophrenia

Indexed keywords

ANTIDIABETIC AGENT; ATENOLOL; ATYPICAL ANTIPSYCHOTIC AGENT; BENDROFLUMETHIAZIDE; CLOZAPINE; GLICLAZIDE; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; LITHIUM CARBONATE; LORAZEPAM; OLANZAPINE; PROMETHAZINE; RISPERIDONE; THYROXINE; ZOLPIDEM; ZUCLOPENTHIXOL DECANOATE;

ADULT; ARTICLE; CASE REPORT; DIABETIC KETOACIDOSIS; DIET THERAPY; ELECTROCONVULSIVE THERAPY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; MALE; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PARANOID SCHIZOPHRENIA; PATIENT MONITORING; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; CLOZAPINE; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PSYCHOTIC DISORDERS; SCHIZOPHRENIA, PARANOID;

EID: 17744392467     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105049043     Document Type: Article

References (20)

1. Ardizzone T D, Bradley R J, Freeman A M, Dwyer D S (2001) Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine and structural analogues of clozapine. Brain Res 923: 82-90
2. Avram A M, Patel V, Taylor H C, Kirwan J P, Kalhan S (2001) Euglycaemic clamp study in clozapine-induced diabetic ketoacidosis. Ann Pharmacother 35: 1381-1387
3. Dwyer D S, Liu Y, Bradley R J (1999a) Dopamine receptor antagonists modulate glucose uptake in rat phaeochromocytoma (PC12) cells. Neurosci Lett 274: 151-154
4. Dwyer D S, Pinkofsky H B, Liu Y, Bradley R J (1999b) Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells. Prog Neuropsychopharmacol Biol Psychiatry 23: 69-80
5. Gould G W, Holman G D (1993) The glucose transporter family. Biochem J 295: 329-341
6. Henderson D C (2001) Clozapine: diabetes mellitus, weight gain and lipid abnormalities. J Clin Psychiatry 62 (Suppl 23): 39-44
7. Koller E, Schneider B, Bennett K, Dubitsky G (2001) Clozapine-associated diabetes. Am J Med 111: 716-23
8. Koro C E, Fedder D O, L'Italien G J, Weiss S S, Magder L S, Kreyenbuhl J, Revicki D A, Buchanan R W (2002) Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case control study. Br Med J 325: 243-245
9. Leonard P, Halley A, Browne S (2002) Prevalenece of obesity, lipid and glucose abnormalities in outpatients prescribed clozapine. Irish Med J 95: 119-120
10. Lindenmayer J P, Nathan A M, Smith R C (2001) Hyperglycaemia associated with the use of atypical antipsychotics. J Clin Psychiatry 174: 180-181
11. Livingstone C, Dominiczak A F, Campbell I W, Gould G W (1995) Insulin resistance, hypertension and GLUT4. Clin Sci 89: 109-116
12. Livingstone C, Rampes H (2003) Atypical antipsyhotic drugs and diabetes. Pract Diab Int 20: 327-331
13. Mohan D, Gorden H, Hindley N, Barker A (1999) Schizophrenia and diabetes mellitus. Br J Psychiatry 174: 180-181
14. Moller D E, Flier J S (1991) Insulin resistance - mechanisms, syndromes and implications. N Eng J Med 325: 938-948
15. Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R (1999) Active monitoring of 12760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry 175: 576-580
16. Newcomer J W, Haupt D W, Fucetola R, Melson A K, Schweiger J A, Cooper B P, Selke G (2002) Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch Gen Psychiatry 59: 337-345
17. Ramankutty G (2002) Olanzapine-induced destabilisation of diabetes in the absence of weight gain. Acta Psychiatr Scand 105: 235-236
18. Taha C, Klip A (1999) The insulin signaling pathway. J Membr Biol 169: 1-12
19. 14C]-2-deoxyglucose uptake in response to long term clozapine administration in rats. Neuropsychobiology 44: 36-40
20. Wirsching D A, Boyd J A, Meng L R, Ballon J S, Marder S R, Wirshing W C (2002). The effects of novel antipsychotics on glucose and lipid levels. J Clin Psychiatry 63: 856-865